EP0281251A3 - A method for preparing a fecal sample composition for immunoassay testing - Google Patents

A method for preparing a fecal sample composition for immunoassay testing Download PDF

Info

Publication number
EP0281251A3
EP0281251A3 EP88300924A EP88300924A EP0281251A3 EP 0281251 A3 EP0281251 A3 EP 0281251A3 EP 88300924 A EP88300924 A EP 88300924A EP 88300924 A EP88300924 A EP 88300924A EP 0281251 A3 EP0281251 A3 EP 0281251A3
Authority
EP
European Patent Office
Prior art keywords
sample
fecal
analyte
stool
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP88300924A
Other languages
German (de)
French (fr)
Other versions
EP0281251A2 (en
Inventor
Michael A. Grow
Vipin D. Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Immunoassay Laboratories Inc
Original Assignee
International Immunoassay Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Immunoassay Laboratories Inc filed Critical International Immunoassay Laboratories Inc
Publication of EP0281251A2 publication Critical patent/EP0281251A2/en
Publication of EP0281251A3 publication Critical patent/EP0281251A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/725—Haemoglobin using peroxidative activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0038—Devices for taking faeces samples; Faecal examination devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B50/00—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers
    • A61B2050/005—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers with a lid or cover
    • A61B2050/0062—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers with a lid or cover closable by a combination of rotation and translation
    • A61B2050/0064—Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers with a lid or cover closable by a combination of rotation and translation by screwing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Abstract

A method for preparing a fecal sample for immunoassay testing comprising the steps of dispersing a sample of from 1 to less than 10 wt.% of a stool sample in an aqueous fecal test solution formulated with one or more preservatives, analyte stabilizing agents and endogenous interference reducing agents. The fecal solids are then permitted to settle to form a liquid phase substantially free from fecal solids, and the clarified liquid phase is removed to provide a test sample free from fecal solids. The fecal test solutions contain suitable stool stabilizers such as buffers and antimicrobial agents, analyte protecting agents such as proteolytic, reductive or oxidative enzyme inhibitors, endogenous assay interfering enzyme inhibitors such as a reducing agent, and non-specific binding inhibitors such as animal proteins. The stool sample should be fresh or be fresh frozen and thawed immediately before dispersion in the buffer solution. The sample is suitable for any solid-phase immunoassay determination of a fecal sample analyte.
A method for determining analyte in a stool sample comprises conjugating anti-analyte antibody adhered to a insoluble support with analyte in the clarified sample, and determining the presence and extent of such conjugation. For determining human hemoglobin in a sample of human stool, the aqueous fecal test solution preferably contains a proteinase inhibitor, formaldehyde and an animal albumin.
EP88300924A 1987-02-04 1988-02-03 A method for preparing a fecal sample composition for immunoassay testing Ceased EP0281251A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1078787A 1987-02-04 1987-02-04
US10787 1987-02-04

Publications (2)

Publication Number Publication Date
EP0281251A2 EP0281251A2 (en) 1988-09-07
EP0281251A3 true EP0281251A3 (en) 1988-09-28

Family

ID=21747430

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88300924A Ceased EP0281251A3 (en) 1987-02-04 1988-02-03 A method for preparing a fecal sample composition for immunoassay testing

Country Status (3)

Country Link
US (1) US5094956A (en)
EP (1) EP0281251A3 (en)
JP (1) JPS63271160A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3840605A1 (en) * 1988-12-02 1990-06-07 Behringwerke Ag MEDIUM FOR IMMUNCHEMICAL TESTS CONTAINING CARBOXYL GROUP POLYMERS
US5460969A (en) * 1993-03-15 1995-10-24 Fielder; Paul N. Method for differentiating the source of occult gastrointestinal bleeding
US5331973A (en) * 1993-03-15 1994-07-26 Fiedler Paul N Method for obtaining stool samples for gastrointestinal cancer testing
US5385825A (en) * 1993-07-20 1995-01-31 Emerald Biomedical Sciences, Inc. Composition for processing bodyfluids, method of processing bodyfluids and products made from bodyfluids
US5447868A (en) * 1993-09-14 1995-09-05 Propper Manufacturing Co. Inc. Method, reagent and kit for the detection of fecal occult blood
US6057166A (en) * 1995-12-22 2000-05-02 Universal Healthwatch, Inc. Fecal test method
JP2000502452A (en) * 1995-12-22 2000-02-29 ユニバーサル ヘルスウォッチ，インコーポレーテッド Fecal test methods and equipment
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5716791A (en) 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
DK0937259T3 (en) * 1996-11-01 2005-01-31 Magne K Fagerhol Process for extracting proteins
AUPP323798A0 (en) * 1998-04-28 1998-05-21 Chandler, Howard Milne Sample collection method
US6811549B2 (en) * 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US20050124965A1 (en) * 2003-12-08 2005-06-09 Becton, Dickinson And Company Phosphatase inhibitor sample collection system
US20080241940A1 (en) * 2004-07-22 2008-10-02 Lastella Vincent P Fecal sampling device and method
DE602005015517D1 (en) 2004-07-22 2009-09-03 Immunostics Inc Sample test carrier and method for testing occult blood in stool
US8679420B2 (en) * 2004-07-22 2014-03-25 Immunostics, Inc. Fecal sampling device and method
US7427505B2 (en) * 2004-07-22 2008-09-23 Immunostics, Inc. Fecal occult blood testing device and method
CN101072796A (en) * 2004-12-04 2007-11-14 自由健康有限公司 Monoclonal and polyclonal antibodies to equine hemoglobin and apparatus and methods using the antibodies and/or peroxidase reactions in the identification and localization of ulcers in equines
US7629180B2 (en) * 2004-12-04 2009-12-08 Freedom Health, Llc Test kit for the rapid detection and localization of digestive tract bleeding in equines
CA2679725C (en) * 2007-02-28 2015-07-07 Quantrx Biomedical Corporation Folded perineal pad
JP5422108B2 (en) 2007-10-16 2014-02-19 栄研化学株式会社 Heme protein stabilization method and storage solution
US8304596B2 (en) 2008-04-11 2012-11-06 Immunostics, Inc. Fecal sampling device and method
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
JP2018509885A (en) * 2015-01-09 2018-04-12 マーロ，マデュ，エス． Diagnosis and treatment of early diabetes
ES2804551T3 (en) 2015-03-31 2021-02-08 Eiken Chemical Heme Protein Preservative Solution, and Heme Protein Stabilization Procedure
WO2017038711A1 (en) * 2015-08-28 2017-03-09 栄研化学株式会社 Reagent composition for immunological measurement and application for same
ES2963821T3 (en) * 2017-05-11 2024-04-02 Immundiagnostik Ag Procedure and test kit for the quantitative determination of biomarkers in fecal samples
US20210146352A1 (en) * 2017-07-24 2021-05-20 Epitope Diagnostics, Inc. Fecal sample collection and analyte extraction device and method
US20200377572A1 (en) 2017-12-01 2020-12-03 Eiken Kagaku Kabushiki Kaisha Method for stabilizing hemoglobin-haptoglobin complex and a preservation solution for preserving specimens containing hemoglobin
EP3761030A4 (en) 2018-03-02 2022-03-02 Eiken Kagaku Kabushiki Kaisha Method for stabilizing protein contained in sample and solution for stabilizing protein contained in sample
KR20200128412A (en) * 2018-03-02 2020-11-12 에보니크 오퍼레이션즈 게엠베하 In vitro method for detecting intestinal barrier malfunction in animals
WO2020150468A1 (en) * 2019-01-16 2020-07-23 Hall Labs, Llc Toilet equipped to provide fecal analysis
CN111505272A (en) * 2020-04-20 2020-08-07 石家庄洹众生物科技有限公司 Excrement diluent and application thereof
WO2024016048A1 (en) * 2022-07-22 2024-01-25 Howard Chandler Sampling apparatus and method and testing kit and method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030388A2 (en) * 1979-12-10 1981-06-17 Baylor College of Medicine Methods for detecting and quantifying occult blood in a human specimen
EP0032782A2 (en) * 1980-01-17 1981-07-29 Kommandiittiyhtio Finnpipette Osmo A. Suovaniemi Method for the detection of fecal hemoglobin
EP0111916A1 (en) * 1982-12-20 1984-06-27 Memorial Hospital for Cancer and Allied Diseases Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations
EP0175326A2 (en) * 1984-09-17 1986-03-26 Orion Corporation Ltd Diagnostic-test specimen-preparation vial

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869547A (en) * 1971-11-10 1975-03-04 Univ Nebraska Calf diarrhea virus vaccine and processes
US4200690A (en) * 1976-12-16 1980-04-29 Millipore Corporation Immunoassay with membrane immobilized antibody
DE3265794D1 (en) * 1981-07-16 1985-10-03 Hoffmann La Roche Method for the detection of human occult blood in human stool samples
US4424279A (en) * 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4533630A (en) * 1982-09-13 1985-08-06 Wilkins Tracy D Toxins and antibodies of C. difficile
JPH0684970B2 (en) * 1987-03-31 1994-10-26 株式会社京都医科学研究所 Method of detecting occult blood in feces

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030388A2 (en) * 1979-12-10 1981-06-17 Baylor College of Medicine Methods for detecting and quantifying occult blood in a human specimen
EP0032782A2 (en) * 1980-01-17 1981-07-29 Kommandiittiyhtio Finnpipette Osmo A. Suovaniemi Method for the detection of fecal hemoglobin
EP0111916A1 (en) * 1982-12-20 1984-06-27 Memorial Hospital for Cancer and Allied Diseases Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations
EP0175326A2 (en) * 1984-09-17 1986-03-26 Orion Corporation Ltd Diagnostic-test specimen-preparation vial

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCANDINAVIAN JOURNAL OF INFECTIONS DISEASES, vol. 17, 1985, pages 245-249, Stockholm, SE; I. JULKUNEN et al.: "Detection of rotavirus in faecal specimens by enzyme immunoassay, latex agglutination and electron microscopy" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device

Also Published As

Publication number Publication date
US5094956A (en) 1992-03-10
JPS63271160A (en) 1988-11-09
EP0281251A2 (en) 1988-09-07

Similar Documents

Publication Publication Date Title
EP0281251A3 (en) A method for preparing a fecal sample composition for immunoassay testing
ES2009939A6 (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans.
NO930770L (en) IMMUNOLOGICAL PROCEDURE FOR DETERMINING A HEMOGLOBIN DERIVATIVE
IL87682A (en) Method and test system for determining hemoglobin derivatives in blood
PL316794A1 (en) Novel specialised hydrophilic arcidine esters
ES469328A1 (en) Glycoprotein and process for isolating it
DE69132238T2 (en) Process for stabilizing enzyme conjugates
SE8803496D0 (en) REAGENT DURING ANALYSIS
Lacourt et al. Post mortem localization of lysosomal peptide hydrolase, cathepsin B
Lukač et al. Mechanism of liquefaction of the human ejaculate II. Role of collagenase-like peptidase and seminal proteinase
NO945017D0 (en) Diagnostic method for determining susceptibility to solution and a reagent set
EP0693552A3 (en) Analytical element, composition and method using modified apo-horseradish peroxidase
GB9723773D0 (en) Haptoglobin assay
EP0161107A3 (en) Immunometric method for the determination of a hapten
RU2142136C1 (en) STABILIZING MEDIUM FOR α-GST IN URINE AND METHOD FOR DETERMINING QUANTITY OF α-GST IN URINE
Inaba et al. The immunocytochemical localization of new soluble placental tissue proteins (PP 14, 16, 17, 19, 20 and PP 21) in human and Cynomolgus monkey placentae
AU2803695A (en) Assay for inhibitors of dp-1 and other dp proteins
Coll Heme increases peroxidase-antibody activity in aged conjugates
JPS6178385A (en) Stable peroxidase composition
Schifferli et al. A simple two-step procedure for the preparation of the first component of human complement (C1) in its native form
Koren et al. THE COAGULATION OF INSOLUBLE AND BASIC PROTEINS FROM RAT SEMINAL VESICLE SECRETION WITH VESICULASE: INFLUENCE OF COLLAGENASELIKE PEPTIDASE FROM RAT TESTIS
Yoshino et al. Characterization of the lateral interaction between human erythrocyte spectrin subunits
ATE271067T1 (en) MONOCLONAL ANTIBODIES BINDING TO HUMAN GROWTH HORMONE (HGH).
Sekhar et al. Dimethyl suberimidate as an effective crosslinker for antibody-enzyme conjugation
张胜 et al. Study on the Fluorescent Localization of Seminal Vesicle Secretion Protein Ⅱ on the Surface of Rat Sperm

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INTERNATIONAL IMMUNOASSAY LABORATORIES, INC.

17P Request for examination filed

Effective date: 19890316

17Q First examination report despatched

Effective date: 19910301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19920620